期刊文献+

肾性高血压大鼠肥厚心肌中Pyk2表达和激活的变化及缬沙坦的干预研究 被引量:1

The effects of valsartan on changes of Pyk2 expression and activation in myocardium of renovascular hypertensive rats
下载PDF
导出
摘要 目的以肾性高血压大鼠为模型,研究心肌中富脯氨酸蛋白酪氨酸激酶(Pyk2)的表达情况,探讨缬沙坦逆转左室重构的可能机制。方法制备两肾一夹肾性高血压大鼠模型,将大鼠随机分为假手术组、模型组和缬沙坦(30mg·kg^-1·d^-1)组,分别于术前及术后第1、4、8和12周测定动脉血压和心肌肥厚指数,用免疫组化法检测心肌组织中Pyk2及磷酸化Pyk2(p-Pyk2)表达。结果术后4周心肌肥大已发生,8—12周心肌肥大进一步加重,缬沙坦能显著降低肾血管性高血压大鼠的血压,并能有效抑制心肌肥厚的形成(P〈0.01);术后1、4、8和12周大鼠心肌组织Pyk2活性逐渐增加(1周P〈0.05,4、8、12均P〈0.01);缬沙坦组Pyk2及p—Pyk2表达水平下降,与同周龄模型组相比差异有统计学意义(P〈0.01)。结论Pyk2及p—Pyk2在肾性高血压大鼠心肌组织内表达增高,且与心肌肥厚同步;缬沙坦能下调Pyk2及p—Pyk2的表达。这可能是AT1受体拮抗剂逆转心肌肥厚重构的机制之一。 Objective To study the effects of valsartan on ventricular hypertrophy and the expression of Proline-rich tyrosine kinase 2 (Pyk2) in myocardium of renovascular hypertensive rats(RHR). Methods Two- kidney and one-clip(2K1C) renal hypertensive model was established in Sprague-Dawley rats by chronic partial occlusion of left renal artery. Rats were randomly divided into model-operation group, sham-operation group and valsartan group. Rats in valsartan group received valsartan 30 mg. kg^- 1·d^-1. Left ventricular mass to body mass ratio was measured to assay the degree of myocardial hypertrophy. Expression of Pyk2 protein and tyrosine-phosphorylated Pyk2 (p-Pyk2) were detected by immunohistochemisry. Results Blood pressure (BP), left ventricular mass to body mass ratio, Pyk2 activity in myocardium of RHR were increased gradually. Valsartan could reverse the high BP level of the model,also the myocardial hypertrophy(P 〈0.01 ). Pyk2 levels and the amount of p-Pyk2 were measured by Western-Blotting, they were evidently increased in the model-operation group than that of the sham-operation group( lweek P 〈0.05,4 to 12 weeks P 〈0.01 ). Pyk2 and p-Pyk2 levels were significantly dicreased in valsartan group than that of their time-matched model-operation groups (P 〈 0. 01 ). Conclusion Increased expression of Pyk2 and p-Pyk2 in the left ventricle of RHR is probably associated with the progress of the left ventricular hypertrophy (LVH). The preventive mechanism of valsartan cardiac hypertrophy in RHR is related to the decrease of Pyk2 expression and its activity in cardiac tissue.
出处 《现代医学》 2009年第2期100-104,共5页 Modern Medical Journal
关键词 富脯氨酸蛋白酪氨酸激酶 心肌肥大 缬沙坦 肾性高血压 大鼠 酪氨酸磷酸化 Proline-rich tyrosine kinase 2 cardiac hypertrophy valsartan renal hypertension rats tyrosine phosphorylation
  • 相关文献

参考文献13

  • 1Sussman M A,McCulloch A,Borg T K. Dance band on the Tltanic. Biomechanical signaling in cardiac hypertrophy [ J ]. Circ Res.2002.91 (10) :888-898. 被引量:1
  • 2Takahashi T. Pyk2/CAKbeta signaling: a novel Ca (2 + )-dependent pathway leading to cardiac hypertrophy [ J ] . Mol Cell Cardiol, 2004,36 ( 6 ) : 791-793. 被引量:1
  • 3Bayer A L, Heidkamp M C, Patel N, et al. PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy [ J ]. Am J Physiol Heart Circ Physiol, 2002,283 (2) : H695-706. 被引量:1
  • 4Matsubara L S, Narikawa S, Ferreira A L, et al. Myocardial remodeling in chronic pressure or volume overload in the rat heart [ J ]. Arq Bras Cardiol, 2006, S6 (2) : 126-130. 被引量:1
  • 5Bayer A L, Ferguson A G, Lucchesi P A, et al. Pyk2 expression and phosphorylation in neonatal and adult cardiomyocytes [ J ]. J Mol Cell Cardiol,2001,33 (5) : 1017-1030. 被引量:1
  • 6Mehta P K, Griendling K K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascar ststem [ J ]. Am J Physiol Cell Physiol, 2007,292 ( 1 ) : C82- 97. 被引量:1
  • 7姜华,曲鹏,刘宇飞,王圣.Janus激酶转导和转录活化因子(Stat3)在Goldblatt鼠左室肥厚心肌中的变化以及缬沙坦干预后的变化[J].高血压杂志,2004,12(6):542-546. 被引量:3
  • 8Yin G, Yan C, Berk B C. Angiotensin Ⅱ signaling pathways mediated.by tyrosine kinases [ J ]. Int J Biochem Cell Biol, 2003,35(6) :780-783. 被引量:1
  • 9Melendez J, Turner C, Avraham H, et al. Cardiomyocyte apoptosis triggered by RAFFK/pyk2 via src kinase is antagonized by paxillin[ J]. J Biol Chem ,2004,279(51 ) :53516-53523. 被引量:1
  • 10Ohtsu H, Mifune M, Frank G D, et al. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin Ⅱ[ J ]. Arterioscler Thromb Vasc Biol,2005,25 (9) : 1831-1836. 被引量:1

二级参考文献34

共引文献12

同被引文献14

  • 1郝嘉,严俊,肖颖彬.PYK_2小干扰RNA对成年大鼠心脏成纤维细胞增殖的影响[J].第三军医大学学报,2005,27(23):2331-2334. 被引量:1
  • 2郝嘉,郭红,吕伟,严俊,肖颖彬.PYK2靶向短发夹RNA干扰重组体的构建及鉴定[J].中国病理生理杂志,2006,22(11):2278-2280. 被引量:1
  • 3Santiago J J, Dangerfield A L, Rattan S G, et al. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro : expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts[J]. Dev Dyn, 2010, 239(6) : 1573 - 1584. 被引量:1
  • 4Basile J R, Afkhami T, Gutkind J S. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Sre, and the phosphatidylinositol 3-kinase-Akt pathway [ J ]. Mol Cell Biol, 2005, 25( 16): 6889-6898. 被引量:1
  • 5Sousa L P, Carmo A F, Rezende B M, et al. Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K/Akt and NF-kappaB[J]. Biochem Pharmacol, 2009, 78(4) : 396 -405. 被引量:1
  • 6Porter K E, Turner N A. Cardiac fibroblasts : at the heart of myocardial remodeling[J]. Pharmacol.Ther, 2009, 123(2) : 255 -278. 被引量:1
  • 7Krenning G, Zeisberg E M, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis [ J ]. J Cell Physiol, 2010, 225 ( 3 ) :631 - 637. 被引量:1
  • 8Souders C A, Bowers S L, Baudino T A. Cardiac fibroblast: the renaissance cell[J]. Cite Res, 2009, 105(12): 1164-1176. 被引量:1
  • 9Riggs D, Yang Z, Kloss J ,et al. The Pyk2 FERM regulates Pyk2 complex formation and phosphorylation [ J ]. Cell Signal, 2011, 23 ( 1 ) : 288 - 296. 被引量:1
  • 10Lipinski C A, Loftus J C. Targeting Pyk2 for therapeutic intervention [J]. Expert Opin Ther Targets, 2010, 14(1 ) : 95 - 108. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部